Naim Khoury, Cyril Dargazanli, Adrien Guenego, Kevin Zuber, Asya Ekmen, Guillaume Charbonnier, Solène Hebert, Jean Capron, Candice Sabben, Erwan Morvan, William Boisseau, Benjamin Maier, Kévin Premat, Frédéric Clarençon, Stanislas Smajda, Hocine Redjem, Vanessa Chalumeau, Gregoire Boulouis, Annaëlle Chetrit, Augustin Lecler, Patricia Koskas, Loic Duron, Gabriele Ciccio, Célina Ducroux, Simon Escalard, Jean Philippe Desilles, Mylène Hamdani, Bertrand Lapergue, Mikael Mazighi, Malek Ben Maacha, Nahida Brikci-Nigassa, Raphael Blanc, Michel Piotin, Robert Fahed
PURPOSE: The DAWN trial (Diffusion weighted imaging or CT perfusion Assessment with clinical mismatch in the triage of Wake-up and late presenting strokes undergoing Neurointervention with Trevo) has demonstrated the benefits of thrombectomy in patients with unknown or late onset strokes, using automated software (RAPID) for measurement of infarct volume. Because RAPID is not available in all centers, we aimed to assess the accuracy and repeatability of visual infarct volume estimation by clinicians and the consequences for thrombectomy decisions based on the DAWN criteria...
September 2019: Journal of Neurointerventional Surgery